Public consultation on ICH Guideline Q5A(R2) “Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin” launched in Switzerland

2. Dezember 2022 – Swissmedic launches the public consultation on Guideline Q5A(R2) of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH Guidelines), with a deadline of 10 February 2023 for comments.

For more information, see here.